Herpes zoster rhabdomyolysis is rare, severe, and easy to miss because it can begin after the rash has already healed. In this case a 63-year-old woman hit a creatine kinase of 186,383 U/L two weeks after a T12 shingles rash had settled on topical acyclovir. Twelve days of intensive care, nine days of continuous renal replacement therapy, and levothyroxine for VZV-triggered hypothyroidism followed.
Why herpes zoster rhabdomyolysis is easy to miss
Varicella-zoster virus reactivation gives you dermatomal vesicles and neuralgic pain, and that is where clinical attention goes. Postherpetic neuralgia, neurological complications, maybe secondary bacterial infection of the skin. Rhabdomyolysis is not on that list for most clinicians, and there is a reason: non-traumatic rhabdomyolysis usually follows influenza or coxsackievirus, and VZV-associated cases are reported rarely enough that the mechanism, the clinical pattern, and the risk factors in older patients are all still poorly described.
Two features make herpes zoster rhabdomyolysis dangerous rather than merely rare. It progresses fast, and it hides behind a resolved rash.
Escalation to acute kidney injury, severe electrolyte disturbance, and multi-organ dysfunction can happen within days. And in older patients, blunted symptoms combined with skin lesions that have already healed routinely push the diagnosis back. By the time the creatine kinase lands, the muscle is already gone.
Most reported VZV-associated rhabdomyolysis cases happen during primary varicella in children. Severe disease triggered by zoster reactivation in an adult is a different event, and a much less documented one.
What the presentation looked like
She was 63, with no thyroid disease, no thyroid medication, no recent heat exposure, no trauma, no strenuous exercise, no toxic exposure, and no family history of myopathy.
Herpes zoster rhabdomyolysis began, as far as the history can establish it, with a rash. Two weeks before admission she developed a painful erythematous rash over the left T12 dermatome, was diagnosed with shingles at a local clinic, and was treated with topical acyclovir plus oral symptomatic medication. The pain settled in three to four days and left pigmentation behind. No new lesions appeared.
Six days before admission came fever, cough, sputum, and diffuse muscle soreness. Empirical azithromycin did nothing. Over the next four days the fever went but the myalgia got much worse, along with generalized edema, a steep drop in urine output, and urine the color of wine. Creatine kinase went from 4,383 U/L to 32,183 U/L inside 48 hours.
| Admission finding | Value |
|---|---|
| Temperature | 37.0 degrees Celsius |
| Pulse | 91 beats per minute |
| Respiratory rate | 17 breaths per minute |
| Blood pressure | 145/73 mmHg |
| Oxygen saturation | 96 percent on nasal cannula oxygen |
| Consciousness | Alert but lethargic |
| Muscle strength | Grade 3 out of 5 in all four limbs |
| Skin | Residual brownish hyperpigmentation over the left T12 dermatome, no active vesicles |
| Edema | Severe facial and extremity edema |
The creatine kinase curve
These numbers are extreme even by rhabdomyolysis standards, and they read better as a trajectory than as a single value.
| Marker | On admission | Peak during admission | Day 12 | Reference range |
|---|---|---|---|---|
| Creatine kinase | 186,383 U/L | 186,383 U/L | 3,381 U/L | 40 to 200 |
| Lactate dehydrogenase | 3,807 U/L | 5,637 U/L | 414 U/L | Below 250 |
| Aspartate aminotransferase | 2,070 U/L | 2,854 U/L | 89 U/L | Below 40 |
| Creatinine | 67.8 umol/L | 359.6 umol/L on day 12 | 359.6 umol/L | 41 to 81 |
| Blood urea nitrogen | 8.82 mmol/L | 41.96 mmol/L on day 12 | 41.96 mmol/L | 3.1 to 8.8 |
Creatine kinase peaked at 186,383 U/L, roughly 930 times the upper limit of the reference range. The other muscle injury markers moved with it: CK-MB 1,079 ng/mL, alanine aminotransferase 565 U/L, troponin-I 0.374 ng/mL. Urinalysis showed occult blood 3+, protein 2+, and markedly elevated erythrocytes, all consistent with myoglobinuria.
One sequencing detail matters more than it looks. Admission creatinine was normal at 67.8 umol/L. The muscle injury came first and the kidney injury followed, which rules out a primary renal process driving the whole picture.
The daily trajectory that CRRT produced
| Hospital day | CK (U/L) | LDH (U/L) | AST (U/L) | Creatinine (umol/L) | BUN (mmol/L) | Urine output (mL/24 h) |
|---|---|---|---|---|---|---|
| 1 | 186,383 | 5,637 | 2,854 | 67.8 | 8.82 | 8 |
| 2 | 151,923 | 3,823 | 2,789 | 99.8 | 8.19 | 3 |
| 3 | 106,128 | 3,124 | 3,195 | 104.6 | 9.17 | 0 |
| 4 | 96,801 | 2,154 | 1,734 | 104.1 | 9.07 | 34 |
| 5 | 55,622 | 1,630 | 1,003 | 116.0 | 10.87 | 21 |
| 6 | 28,807 | 1,297 | 583 | 108.5 | 13.59 | 31 |
| 7 | 13,964 | 1,051 | 367 | 105.1 | 13.39 | 80 |
| 8 | 7,122 | 962 | 233 | 101.8 | 13.14 | 470 |
| 9 | 3,808 | 789 | 160 | 103.8 | 14.24 | 345 |
| 10 | 2,499 | 650 | 111 | 105.5 | 11.68 | 356 |
| 11 | 1,774 | 503 | 118 | 233.3 | 25.5 | 141 |
| 12 | 3,381 | 414 | 89 | 359.6 | 41.96 | Not available |
Urine output was 8 mL on day 1 and zero on day 3. Continuous veno-venous hemodiafiltration ran for nine straight days and came off on day 10, after which creatinine rebounded to a peak of 359.6 umol/L on day 12 before partially recovering. Urine output did not start improving until day 8.
What the muscle biopsy ruled in and out
Biopsy of the right biceps brachii showed extensive myofiber necrosis, degeneration and lysis, marked fiber size variation with scattered atrophic fibers, and prominent endomysial edema. No inflammatory cell infiltration.
That last clause carries the argument. Influenza-associated viral myositis usually shows intramuscular inflammatory infiltration and viral antigens inside damaged myofibers. This biopsy showed neither, which is why direct VZV lytic infection of muscle was judged unlikely to be the primary driver.
The autoimmune workup was useful by being negative. All 44 myositis-specific and myositis-associated antibodies came back negative, which excluded autoimmune necrotizing myositis. Thigh MRI showed diffuse subcutaneous edema and intramuscular fluid collection with no focal inflammatory mass, again pointing away from a localized inflammatory myopathy.
The three-hit model that explains an extreme CK
This is the part with the most explanatory value, and it is a model rather than proof.
Hit one: VZV reactivation. The index event was T12-dermatome reactivation, two weeks before admission.
Hit two: cytokine-driven muscle injury. Reactivation can set off systemic immune activation with release of tumor necrosis factor alpha and interleukin-6. Her admission inflammatory markers were CRP 147.4 mg/L, procalcitonin 2.98 ng/mL, and interleukin-6 398 pg/mL. Circulating cytokines compromise sarcolemmal integrity, disturb intracellular calcium handling, and produce myofiber necrosis without much local inflammation, which matches this biopsy exactly.
Hit three: hypothyroidism as a permissive co-factor. TSH was 6.24 mIU/L against a reference of 0.60 to 4.40, free T3 1.67 pmol/L against 3.45 to 5.50, and free T4 8.17 pmol/L against 11.00 to 17.70. Anti-thyroglobulin and thyroid peroxidase antibodies were both normal, so this was secondary rather than autoimmune. Hypothyroidism impairs skeletal muscle mitochondrial metabolism, reduces ATP turnover, alters intramuscular glycogen storage, and destabilizes muscle cell membranes.
On its own, hypothyroidism rarely produces fulminant rhabdomyolysis at this level. What it plausibly did was lower the threshold, so cytokine stress from the reactivation caused far more damage than it would have alone. Two hits that are each survivable produced a third state that nearly was not.
Why acyclovir crystal nephropathy had to be excluded
Any patient with acute kidney injury who has recently had acyclovir needs crystal nephropathy considered. The mechanism is real: acyclovir can precipitate in renal tubules and cause obstructive nephropathy. It is also one of the few drug causes of AKI where management changes immediately, because the answer is hydration and dose adjustment rather than immunosuppression.
It was excluded here on two grounds. She had only topical acyclovir with no systemic exposure, and urine crystal counting came back below 1 per microliter, which effectively rules out crystalluria.
Separating myoglobin-induced AKI from drug-crystal nephropathy is a real clinical problem, and fractional excretion of sodium helps. Hers was 0.64 percent, well under 1 percent, consistent with a pre-renal and pigment-driven picture rather than intrinsic tubular obstruction.
The wider point for anyone managing severe shingles: systemic antiviral therapy with acyclovir or valacyclovir is the standard way to limit viral replication, and topical acyclovir alone does not count as systemic treatment. Whether earlier systemic therapy would have prevented this cascade is not something one case can answer.
What the treatment actually consisted of
Management was multidisciplinary from day one and ran on six fronts.
| Domain | Intervention |
|---|---|
| Respiratory | Emergency endotracheal intubation and mechanical ventilation on admission day, percutaneous tracheostomy on day 6 |
| Renal | Femoral venous dialysis catheter, continuous veno-venous hemodiafiltration for 9 consecutive days |
| Anti-infective | Empirical piperacillin-tazobactam, escalated to meropenem 1 g every 8 hours for persistent pulmonary infection |
| Etiological | Low-dose methylprednisolone 40 mg per day for immune dysregulation, plus levothyroxine replacement |
| Supportive | Early enteral nutrition via nasointestinal tube, physical thromboprophylaxis |
| Monitoring | Serial creatine kinase, lactate dehydrogenase, and aspartate aminotransferase throughout |
By day 12 the edema had resolved and muscle strength had recovered. She came off ventilation and moved to a general ward. No recurrence during follow-up.
Practical checklist
- Suspect herpes zoster rhabdomyolysis in any older patient with unexplained myalgia and a recent shingles history.
- Ask about shingles in any older patient with unexplained myalgia, even when no rash is visible. Ask specifically about a rash two to four weeks back.
- Look for residual dermatomal hyperpigmentation. Once the vesicles heal, it is the only physical trace left.
- Order creatine kinase immediately when an older shingles patient reports persistent generalized myalgia, regardless of blister status.
- Add thyroid function testing to any markedly elevated creatine kinase. Treatable hypothyroidism may be lowering the damage threshold.
- Check urine crystal counts and calculate fractional excretion of sodium whenever acyclovir has been used, to separate crystal nephropathy from myoglobin injury.
- Run the myositis antibody panel. Forty-four negative antibodies is what ruled out autoimmune necrotizing myositis here.
- Escalate to continuous renal replacement therapy early. Nine days of it carried her through the oliguric phase.
- Expect a creatinine rebound after CRRT stops. Hers peaked on day 12, two days after discontinuation.
Limitations
This is a single case report, so it establishes mechanistic plausibility rather than causation. One case of herpes zoster rhabdomyolysis cannot define incidence, risk factors, or the frequency with which thyroid dysfunction contributes. No VZV PCR or viral immunohistochemistry was run on the muscle specimen, so low-level intramuscular viral presence was never fully excluded. Admission inflammatory markers confirmed severe systemic inflammation, but serial cytokine measurements were unavailable, so the cytokine injury model could not be tracked over time. Whether the thyroid dysfunction was triggered by VZV or was an independent coincidental finding cannot be settled with one patient. And the three-hit model fits the biopsy and the laboratory pattern without being a demonstrated pathway.
Bottom line
Herpes zoster rhabdomyolysis can begin after the shingles rash has healed, which is exactly why it gets missed. Here it produced a creatine kinase of 186,383 U/L, nine days of continuous renal replacement therapy, twelve days of intensive care, and a stage 3 acute kidney injury, all two weeks after a T12 rash had settled on topical acyclovir. The practical version is short: persistent generalized myalgia in an older shingles patient needs an immediate creatine kinase and a thyroid panel, blisters or no blisters.
FAQ
What is herpes zoster rhabdomyolysis
Herpes zoster rhabdomyolysis is severe skeletal muscle breakdown triggered by varicella-zoster virus reactivation. It is an extremely rare complication of shingles that can escalate within days to acute kidney injury, severe electrolyte disturbance, and multi-organ failure. Most reported VZV-associated cases occur during primary chickenpox in children.
Can shingles cause rhabdomyolysis after the rash heals
Yes. In this case creatine kinase reached 186,383 U/L roughly two weeks after the dermatomal rash had resolved, leaving only residual hyperpigmentation. That delay is the main reason the diagnosis is missed, because clinicians stop looking for shingles once the vesicles are gone.
What creatine kinase level defines severe rhabdomyolysis
There is no single threshold, but this case peaked at 186,383 U/L against a reference range of 40 to 200 U/L, roughly 930 times the upper limit. Clinically, the trajectory matters as much as the peak: this patient went from 4,383 to 32,183 U/L within 48 hours.
Why did the kidneys fail
Acute kidney injury followed massive myoglobin release from necrotic muscle. Admission creatinine was normal at 67.8 umol/L, confirming the muscle injury came first. Myoglobin is directly toxic to renal tubules, and urine output fell to 0 mL on day 3 before continuous renal replacement therapy was started.
What role did hypothyroidism play
Hypothyroidism acted as a permissive co-factor rather than a sole cause. TSH was 6.24 mIU/L with low free T3 and free T4 and normal thyroid antibodies, indicating secondary dysfunction. Hypothyroidism impairs muscle mitochondrial metabolism and destabilizes cell membranes, lowering the threshold for cytokine-driven injury.
Was this caused by acyclovir
No. Acyclovir crystal nephropathy was explicitly excluded because the patient received only topical acyclovir with no systemic exposure, and urine crystal counting was below 1 per microliter. Fractional excretion of sodium at 0.64 percent also pointed away from tubular obstruction.
Is topical acyclovir enough for shingles
Topical acyclovir treats the skin lesions but is not systemic antiviral therapy. Standard management of herpes zoster uses systemic acyclovir or valacyclovir to limit viral replication. Whether earlier systemic therapy would have prevented this cascade is not something a single case report can establish.
How is rhabdomyolysis from shingles treated
Treatment is supportive and organ-directed. This patient received nine days of continuous veno-venous hemodiafiltration, mechanical ventilation with tracheostomy on day 6, antibiotics for aspiration pneumonia, low-dose methylprednisolone, and levothyroxine replacement. Creatine kinase fell from 186,383 to 3,381 U/L by day 12.
How is autoimmune myositis ruled out
A myositis antibody panel and a muscle biopsy. Here all 44 myositis-specific and myositis-associated antibodies were negative. Biopsy showed extensive myofiber necrosis and endomysial edema with no inflammatory cell infiltration, which is the pattern of non-inflammatory rhabdomyolysis rather than autoimmune necrotizing myositis.
What did the muscle biopsy show
Extensive myofiber necrosis, degeneration and lysis, marked fiber size variation with scattered atrophic fibers, and prominent endomysial edema, with no inflammatory cell infiltration. The absence of inflammation distinguishes this from influenza-associated viral myositis, which typically shows intramuscular inflammatory infiltrates.
Why check thyroid function in rhabdomyolysis
Because hypothyroidism raises the risk and severity of muscle injury, and it is treatable. In this case VZV-triggered secondary hypothyroidism plausibly lowered the damage threshold so that cytokine stress produced far more necrosis than it would have alone. Levothyroxine was part of the treatment.
What is the outlook after severe shingles rhabdomyolysis
Recovery is possible with early intensive support. This patient’s edema resolved, muscle strength recovered, and she was weaned from ventilation after 12 days, with no recurrence during follow-up. Outcomes depend heavily on how fast creatine kinase is checked and how early renal replacement therapy starts.

Comments are closed